It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1999.
1999 | Mumbai, Maharashtra, India | Struck OffKrutishil Pharma Private Limited, a struck off private limited company, was established on 19 January 1999 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24230MH1999PTC117926. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Malvika Pankaj Parekh (Director), Ankit Pankaj Parekh (Director), Binoy Pankaj Parekh (Director). Past directors included Pankaj Trambaklal Parekh. It holds no open charges and ₹4.83 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 3 Girnar 69Tardeo Road Tardeo, Mumbai, Maharashtra, 400034.
U24230MH1999PTC117926
117926
19 January 1999
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Krutishil Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Malvika Pankaj Parekh | Director | 19 Jan 1999 | Current |
| Ankit Pankaj Parekh | Director | 12 Apr 1999 | Current |
| Binoy Pankaj Parekh | Director | 12 Apr 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jun 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Krutishil Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Krutishil Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹48,320,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2016 | Axis Bank Limited | ₹4.25 Cr | Satisfied |
| 08 Jan 2014 | Deutsche Bank Ag | ₹5.00 M | Satisfied |
| 23 May 2000 | Syndicate Bank | ₹0.50 M | Satisfied |
| 19 Apr 1999 | Syndicate Bank | ₹0.32 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Krutishil Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Krutishil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krutishil Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 23 May 2000 via Charge ID 90142882 with Syndicate Bank was fully satisfied on 16 Apr 2022. was documented.
Progress on A charge registered on 19 Apr 1999 via Charge ID 90146000 with Syndicate Bank was fully satisfied on 16 Apr 2022. was documented.
A charge registered on 08 Jan 2014 via Charge ID 10481489 with Deutsche Bank Ag was fully satisfied on 30 Mar 2022. was recorded as a recent event.
The activity Krutishil Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Krutishil Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.
The activity A charge registered on 23 May 2016 via Charge ID 100034835 with Axis Bank Limited was fully satisfied on 20 Apr 2017. was completed.
The CIN of Krutishil Pharma Private Limited is U24230MH1999PTC117926.
Krutishil Pharma Private Limited is headquartered at 3 Girnar 69Tardeo Road Tardeo, Mumbai, Maharashtra, 400034.
Krutishil Pharma Private Limited was incorporated on 19 January 1999.
The current directors of Krutishil Pharma Private Limited are
The primary industry of Krutishil Pharma Private Limited is Pharma.
Krutishil Pharma Private Limited is unlisted.
The authorized capital of Krutishil Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Krutishil Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX